| Characterization of phosphorylated peptides using traveling wave-based and drift cell ion mobility mass spectrometry K Thalassinos, M Grabenauer, SE Slade, GR Hilton, MT Bowers, ... Analytical chemistry 81 (1), 248-254, 2009 | 267 | 2009 |
| Potent rewarding and reinforcing effects of the synthetic cathinone 3, 4‐methylenedioxypyrovalerone (MDPV) LR Watterson, PR Kufahl, NE Nemirovsky, K Sewalia, M Grabenauer, ... Addiction biology 19 (2), 165-174, 2014 | 199 | 2014 |
| Characterization of simple isomeric oligosaccharides and the rapid separation of glycan mixtures by ion mobility mass spectrometry JP Williams, M Grabenauer, RJ Holland, CJ Carpenter, MR Wormald, ... International Journal of Mass Spectrometry 298 (1-3), 119-127, 2010 | 141 | 2010 |
| Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles JL Wiley, JA Marusich, TW Lefever, M Grabenauer, KN Moore, ... Neuropharmacology 75, 145-154, 2013 | 132 | 2013 |
| AB-CHMINACA, AB-PINACA, and FUBIMINA: affinity and potency of novel synthetic cannabinoids in producing Δ9-Tetrahydrocannabinol–like effects in mice JL Wiley, JA Marusich, TW Lefever, KR Antonazzo, MT Wallgren, ... Journal of Pharmacology and Experimental Therapeutics 354 (3), 328-339, 2015 | 126 | 2015 |
| Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs M Grabenauer, WL Krol, JL Wiley, BF Thomas Analytical chemistry 84 (13), 5574-5581, 2012 | 102 | 2012 |
| Oligomers of the prion protein fragment 106− 126 are likely assembled from β-hairpins in solution, and methionine oxidation inhibits assembly without altering the peptide’s … M Grabenauer, C Wu, P Soto, JE Shea, MT Bowers Journal of the American Chemical Society 132 (2), 532-539, 2010 | 79 | 2010 |
| Spermine binding to Parkinson’s protein α-synuclein and its disease-related A30P and A53T mutants M Grabenauer, SL Bernstein, JC Lee, T Wyttenbach, NF Dupuis, HB Gray, ... The journal of physical chemistry B 112 (35), 11147-11154, 2008 | 74 | 2008 |
| Carbon dioxide as a solubility “switch” for the reversible dissolution of highly fluorinated complexes and reagents in organic solvents: Application to crystallization PG Jessop, MM Olmstead, CD Ablan, M Grabenauer, D Sheppard, ... Inorganic chemistry 41 (13), 3463-3468, 2002 | 71 | 2002 |
| The effect of calcium ions and peptide ligands on the relative stabilities of the calmodulin dumbbell and compact structures T Wyttenbach, M Grabenauer, K Thalassinos, JH Scrivens, MT Bowers The Journal of Physical Chemistry B 114 (1), 437-447, 2010 | 65 | 2010 |
| Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice JL Wiley, TW Lefever, JA Marusich, M Grabenauer, KN Moore, ... Neuropharmacology 110, 143-153, 2016 | 55 | 2016 |
| Structural analysis of prion proteins by means of drift cell and traveling wave ion mobility mass spectrometry GR Hilton, K Thalassinos, M Grabenauer, N Sanghera, SE Slade, ... Journal of the American Society for Mass Spectrometry 21, 845-854, 2010 | 53 | 2010 |
| Using analysis for problem-solving: A guidebook for law enforcement TS Bynum US Department of Justice, Office of Community Oriented Policing Services, 2001 | 46* | 2001 |
| Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis TR Spindle, EL Martin, M Grabenauer, T Woodward, MA Milburn, ... Journal of psychopharmacology 35 (7), 786-803, 2021 | 44 | 2021 |
| Effects of α‐pyrrolidinopentiophenone and 4-methyl-n-ethylcathinone, two synthetic cathinones commonly found in second-generation “bath salts,” on intracranial self-stimulation … LR Watterson, BT Burrows, RD Hernandez, KN Moore, M Grabenauer, ... International Journal of Neuropsychopharmacology 18 (1), pyu014, 2015 | 44 | 2015 |
| Use of SPME-HS-GC–MS for the analysis of herbal products containing synthetic cannabinoids AO Cox, RC Daw, MD Mason, M Grabenauer, PG Pande, KH Davis, ... Journal of analytical toxicology 36 (5), 293-302, 2012 | 44 | 2012 |
| Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences BF Thomas, TW Lefever, RA Cortes, M Grabenauer, AL Kovach, AO Cox, ... Journal of Pharmacology and Experimental Therapeutics 361 (1), 162-171, 2017 | 43 | 2017 |
| Supramolecular Modification of Ion Chemistry: Modulation of Peptide Charge State and Dissociation Behavior through Complexation with Cucurbit[n]uril (n = 5, 6 … H Zhang, M Grabenauer, MT Bowers, DV Dearden The Journal of Physical Chemistry A 113 (8), 1508-1517, 2009 | 43 | 2009 |
| Conformational stability of syrian hamster prion protein prp (90− 231) M Grabenauer, T Wyttenbach, N Sanghera, SE Slade, TJT Pinheiro, ... Journal of the American Chemical Society 132 (26), 8816-8818, 2010 | 38 | 2010 |
| Identification of eight synthetic cannabinoids, including 5F‐AKB48 in seized herbal products using DART‐TOF‐MS and LC‐QTOF‐MS as nontargeted screening methods KN Moore, D Garvin, BF Thomas, M Grabenauer Journal of forensic sciences 62 (5), 1151-1158, 2017 | 30 | 2017 |
